LightDeck Diagnostics has signed a long-term lease in Longmont, Colorado, where the bioscience company, whose line of products include a COVID-19 antibody test, plans to ramp up its manufacturing capabilities after receiving a grant to scale its operations.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Contacts
- Jeremy Kroner
Senior Vice President, CBRE
- James Bolt
Vice Chairman, CBRE
- David Shirazi
Senior Vice President, JLL